Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
2019
51-100
Los Altos, California, United States
Artificial IntelligenceBiopharmaBiotechnologynologyNeurosciencePrecision Medicine

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

239.M

Last Funding Amount

59.26M

Last Funding Date

27-11-2023

Startup Stage

IPO

Lead Investors

Gaingels, Valor Equity Partners, Franklin Templeton, Eli Lilly, PsyMed Ventures

Revenue

$10M to $50M

People

Founders